- Home
- FKWL vs IPSC Comparison
FKWL vs IPSC Comparison
Compare FKWL & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FKWL
- IPSC
- Stock Information
- Founded
- FKWL 1981
- IPSC 2019
- Country
- FKWL United States
- IPSC United States
- Employees
- FKWL N/A
- IPSC N/A
- Industry
- FKWL Telecommunications Equipment
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- FKWL Utilities
- IPSC Health Care
- Exchange
- FKWL Nasdaq
- IPSC Nasdaq
- Market Cap
- FKWL 45.8M
- IPSC 43.2M
- IPO Year
- FKWL 1996
- IPSC 2021
- Fundamental
- Price
- FKWL $4.43
- IPSC $0.56
- Analyst Decision
- FKWL
- IPSC Strong Buy
- Analyst Count
- FKWL 0
- IPSC 5
- Target Price
- FKWL N/A
- IPSC $3.33
- AVG Volume (30 Days)
- FKWL 20.5K
- IPSC 486.6K
- Earning Date
- FKWL 11-13-2025
- IPSC 11-04-2025
- Dividend Yield
- FKWL N/A
- IPSC N/A
- EPS Growth
- FKWL N/A
- IPSC N/A
- EPS
- FKWL N/A
- IPSC N/A
- Revenue
- FKWL $46,086,901.00
- IPSC $114,128,000.00
- Revenue This Year
- FKWL N/A
- IPSC $1,589.94
- Revenue Next Year
- FKWL N/A
- IPSC N/A
- P/E Ratio
- FKWL N/A
- IPSC N/A
- Revenue Growth
- FKWL 49.65
- IPSC 5491.77
- 52 Week Low
- FKWL $3.67
- IPSC $0.34
- 52 Week High
- FKWL $7.45
- IPSC $1.83
- Technical
- Relative Strength Index (RSI)
- FKWL 61.76
- IPSC 60.86
- Support Level
- FKWL $4.10
- IPSC $0.48
- Resistance Level
- FKWL $4.60
- IPSC $0.51
- Average True Range (ATR)
- FKWL 0.13
- IPSC 0.03
- MACD
- FKWL 0.03
- IPSC 0.01
- Stochastic Oscillator
- FKWL 71.46
- IPSC 67.79
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.